You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Zonisamide Versus Topiramate in Migraine Prophylaxis
|
|---|---|
| Published in |
Clinical Neuropharmacology, July 2011
|
| DOI | 10.1097/wnf.0b013e318225140c |
| Pubmed ID | |
| Authors |
Seyed Ehsan Mohammadianinejad, Vahid Abbasi, Seyed Aidin Sajedi, Nastaran Majdinasab, Fahimeh Abdollahi, Reza Hajmanouchehri, Asal Faraji |
| Abstract |
Topiramate is an antiepileptic drug that has been approved for migraine prophylaxis. Despite appropriate efficacy for migraine prophylaxis, some patients cannot tolerate its adverse effects. The aim of this study was to compare the efficacy of zonisamide, another antiepileptic drug, with topiramate in decreasing the frequency and severity of migraine attacks to determine whether it could be used as an alternative for noncompliant patients to topiramate. |
Mendeley readers
The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 32 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 5 | 16% |
| Student > Postgraduate | 4 | 13% |
| Researcher | 4 | 13% |
| Other | 4 | 13% |
| Student > Bachelor | 3 | 9% |
| Other | 7 | 22% |
| Unknown | 5 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 16 | 50% |
| Agricultural and Biological Sciences | 2 | 6% |
| Unspecified | 1 | 3% |
| Computer Science | 1 | 3% |
| Arts and Humanities | 1 | 3% |
| Other | 4 | 13% |
| Unknown | 7 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 August 2011.
All research outputs
#22,759,452
of 25,374,647 outputs
Outputs from Clinical Neuropharmacology
#730
of 815 outputs
Outputs of similar age
#117,912
of 127,143 outputs
Outputs of similar age from Clinical Neuropharmacology
#5
of 6 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 815 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 127,143 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one.